Sustainable transformation

through innovation

ELCH, Consulting, Services, Innovation, Text

innovation

our approach 

Science and technology-driven companies typically have strong innovation capabilities. They still face challenges such as tighter budgets, stricter regulations and stakeholders who require stronger governance and transparency. Digitalization brings about new entrants in established industries. Companies need to implement more sustainable business models and leverage their innovation capabilities to create societal impact.

ELCH proposes a lean approach to uplifting a company‘s innovation management with a focus on sustainability and agility.

We thereby focus on the six elements of any innovation system

ELCH, Consulting, Services, Innovation, Graphic 02

This leads to tangible results after 90 days and sets the foundation for smooth scale-up

ELCH, Consulting, Services, Innovation, Graphic 01

Whilst building and advancing innovation systems in various industries, ELCH has a team of specialists with a particular focus on pharma R&D

what

  • Pharmaceutical R&D is facing change driven by regulators, payers, patients, competitors, new (tech) entrants
  • Drug programs and pipelines increasingly require a combination of scientific, clinical, regulatory, tech and business know-how at the same time to master evolving environments

how

  • Assessment of as-is situation and definition of to-be state
  • Strategy design and implementation
  • Process management
  • Change management
  • Individual drug programs
  • Project management
  • Support of specific (trial) deliverables

impact

  • Meet regulatory and compliance requirements
  • Improved R&D productivity
  • Ensure competitiveness by creating innovative healthcare solutions
  • Enable delivery at the level of individual drug programs and projects, minimizing risks and accelerating timelines

OUR FOCUS: RESEARCH AND DEVELOPMENT IN CHEMICALS, PHARMA AND LIFE SCIENCES

Example pharmaceutical industry

HOW

  • Analysis of the current state and definition of the target state
  • Conception and implementation of functional and cross-functional (transformation) projects
  • Optimization of processes
  • Change management
  • Direct support of drug development programs through:
    – project management
    – Patient-focused R&D
    – Integrated evidence planning

BENEFITS

  • Development of innovative, patient-oriented healthcare solutions
  • Increased R&D productivity
  • Increased probability of success for development, approval and reimbursement milestones
  • Accelerated market approval and market access
  • Adaptation to rapidly changing market changes and technical-scientific framework conditions 
EN